Cited by 2,456Genetic factors in colorectal cancerColorectal Cancer Treatments and StudiesColorectal Cancer Surgical Treatments

The DOI matches its Crossref record; 218 of the 228 references it cites were found in a registry or an index.

Microsatellite Instability in Colorectal Cancer

Open access

Boland, C. Richard, Goel, Ajay·2010·Gastroenterology

DOI 10.1053/j.gastro.2009.12.064PMC PMC3037515

Open this paper in CoChat — free account

Abstract

Microsatellite instability (MSI) is a hypermutable phenotype caused by the loss of DNA mismatch repair activity. MSI is detected in about 15% of all colorectal cancers; 3% are of these are associated with Lynch syndrome and the other 12% are caused by sporadic, acquired hypermethylation of the promoter of the MLH1 gene, which occurs in tumors with the CpG island methylator phenotype. Colorectal tumors with MSI have distinctive features, including a tendency to arise in the proximal colon, lymphocytic infiltrate, and a poorly differentiated, mucinous or signet ring appearance. They have a slightly better prognosis than colorectal tumors without MSI and do not have the same response to chemotherapeutics. Discovery of MSI in colorectal tumors has increased awareness of the diversity of colorectal cancers and implications for specialized management of patients.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1053/j.gastro.2009.12.064

Cites

218 of 218 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Global cancer statistics
Jemal, A., Bray, F., Ferlay, J., Ward, E., & Forman, D. (2011) · CA A Cancer Journal for Clinicians · doi:10.3322/caac.20107 · Cited by 55,044
The hallmarks of cancer
Hanahan, D., & Weinberg, R. A. (2000) · Cell · doi:10.1016/s0092-8674(00)81683-9 · Cited by 29,219
A genetic model for colorectal tumorigenesis
Fearon, E. R., & Vogelstein, B. (1990) · Cell · doi:10.1016/0092-8674(90)90186-i · Cited by 12,132
Cancer statistics, 2012
Siegel, R., Naishadham, D., & Jemal, A. (2012) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.20138 · Cited by 10,679
PD-1 Blockade in Tumors with Mismatch-Repair Deficiency
Le, D. T., Uram, J. N., Wang, H., Bartlett, B. R., Kemberling, H., Eyring, A. D., Skora, A. D., Luber, B. S., Azad, N. S., Laheru, D., et al. (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1500596 · Cited by 9,377
Comprehensive molecular characterization of human colon and rectal cancer
The Cancer Genome Atlas Network (2012) · Nature · doi:10.1038/nature11252 · Cited by 8,499
Type, Density, and Location of Immune Cells Within Human Colorectal Tumors Predict Clinical Outcome
Galon, J., Costes, A., Sanchez-Cabo, F., Kirilovsky, A., Mlecnik, B., Lagorce-Pagès, C., Tosolini, M., Camus, M., Berger, A., Wind, P., et al. (2006) · Science · doi:10.1126/science.1129139 · Cited by 6,516
The consensus molecular subtypes of colorectal cancer
Guinney, J., Dienstmann, R., Wang, X., de Reyniès, A., Schlicker, A., Soneson, C., Marisa, L., Roepman, P., Nyamundanda, G., Angelino, P., et al. (2015) · Nature Medicine · doi:10.1038/nm.3967 · Cited by 5,170
A National Cancer Institute Workshop on Microsatellite Instability for cancer detection and familial predisposition: development of international criteria for the determination of microsatellite instability in colorectal cancer.
Boland, C. R., Thibodeau, S. N., Hamilton, S. R., Sidransky, D., Eshleman, J. R., Burt, R. W., Meltzer, S. J., Rodrı́guez-Bigas, M. A., Fodde, R., Ranzani, G. N., et al. (1998) · PubMed · Cited by 4,087
Self-citation
Revised Bethesda Guidelines for Hereditary Nonpolyposis Colorectal Cancer (Lynch Syndrome) and Microsatellite Instability
Umar, A., Boland, C. R., Terdiman, J. P., Syngal, S., de la Chapelle, A., Rüschoff, J., Fishel, R. A., Lindor, N. M., Burgart, L. J., Hamelin, R., et al. (2004) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djh034 · Cited by 3,181
Self-citation

Show all 228 references

Sorted by citations

Items 701–800 of 1,002

Immunohistochemical evaluation of tumor budding for stratifying T1 colorectal cancer: optimal cut-off value and a novel computer-assisted semiautomatic method
Takamatsu, M., Kawachi, H., Yamamoto, N., Kobayashi, M., Toyama, Y., Maekawa, T., Chino, A., Saito, S., Ueno, M., Takazawa, Y., et al. (2018) · Modern Pathology · doi:10.1038/s41379-018-0189-1 · Cited by 28
Prognostic and therapeutic molecular markers in the clinical management of esophageal cancer
Zhou, N., & Hofstetter, W. L. (2020) · Expert Review of Molecular Diagnostics · doi:10.1080/14737159.2020.1731307 · Cited by 28
In-depth Clinical and Biological Exploration of DNA Damage Immune Response as a Biomarker for Oxaliplatin Use in Colorectal Cancer
Malla, S. B., Fisher, D. J., Domingo, E., Blake, A., Hassanieh, S., Redmond, K. L., Richman, S. D., Youdell, M., Walker, S. M., Logan, G. E., et al. (2020) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-20-3237 · Cited by 28
Mismatch repair deficient-crypts in non-neoplastic colonic mucosa in Lynch syndrome: insights from an illustrative case
Shia, J., Stadler, Z. K., Weiser, M. R., Vakiani, E., Mendelsohn, R. B., Markowitz, A. J., Shike, M., Boland, C. R., & Klimstra, D. S. (2014) · Familial Cancer · doi:10.1007/s10689-014-9751-2 · Cited by 28
Self-citation
CK1α overexpression correlates with poor survival in colorectal cancer
Richter, J., Kretz, A.-L., Lemke, J., Fauler, M., Werner, J.-U., Paschke, S., Leithäuser, F., Henne-Bruns, D., Hillenbrand, A., & Knippschild, U. (2018) · BMC Cancer · doi:10.1186/s12885-018-4019-0 · Cited by 28
From Genomics to AI: Revolutionizing Precision Medicine in Oncology
Calvino, G., Farro, J., Zampatti, S., Peconi, C., Megalizzi, D., Trastulli, G., Andreucci, S., Cascella, R., Strafella, C., Caltagirone, C., et al. (2025) · Applied Sciences · doi:10.3390/app15126578 · Cited by 30
An update on miRNAs as biological and clinical determinants in colorectal cancer: a bench-to-bedside approach
Weng, W., Feng, J., Qin, H., Ma, Y., & Goel, A. (2015) · Future Oncology · doi:10.2217/fon.15.83 · Cited by 28
Self-citation
DNA mismatch repair deficiency and hereditary syndromes in Latino patients with colorectal cancer
Ricker, C. N., Hanna, D. L., Peng, C., Nguyen, N. T., Stern, M. C., Schmit, S. L., Idos, G. E., Patel, R., Tsai, S. C., Ramirez, V., et al. (2017) · Cancer · doi:10.1002/cncr.30790 · Cited by 28
Molecular Biomarkers of Primary and Acquired Resistance to T-Cell-Mediated Immunotherapy in Cancer: Landscape, Clinical Implications, and Future Directions
Chae, Y. K., Oh, M. S., & Giles, F. J. (2017) · The Oncologist · doi:10.1634/theoncologist.2017-0354 · Cited by 28
Low temperature isothermal amplification of microsatellites drastically reduces stutter artifact formation and improves microsatellite instability detection in cancer
Daunay, A., Duval, A., Baudrin, L. G., Buhard, O., Renault, V., Deleuze, J., & How‐Kit, A. (2019) · Nucleic Acids Research · doi:10.1093/nar/gkz811 · Cited by 30
Validation of computational determination of microsatellite status using whole exome sequencing data from colorectal cancer patients
Frydendahl, A., Kassentoft, C. G., Knudsen, M., Laursen, M. B., Madsen, A. H., Iversen, L. H., Gotschalck, K. A., Rasmussen, M. H., & Andersen, C. L. (2019) · BMC Cancer · doi:10.1186/s12885-019-6227-7 · Cited by 29
Two integrated and highly predictive functional analysis-based procedures for the classification of MSH6 variants in Lynch syndrome
Drost, M., Tiersma, Y., Glubb, D. M., Kathe, S. D., van Hees‐Stuivenberg, S., Calléja, F. M. G. R., Zonneveld, J. B. M., Boucher, K. M., Ramlal, R. P. E., Thompson, B. A., et al. (2020) · Genetics in Medicine · doi:10.1038/s41436-019-0736-2 · Cited by 27
Modeling colorectal cancer evolution
Niida, A., Mimori, K., Shibata, T., & Miyano, S. (2021) · Journal of Human Genetics · doi:10.1038/s10038-021-00930-0 · Cited by 31
Transcriptomic Analyses of the Adenoma-Carcinoma Sequence Identify Hallmarks Associated With the Onset of Colorectal Cancer
Hong, Q., Li, B., Cai, X., Lv, Z., Cai, S., Zhong, Y., & Wen, B. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.704531 · Cited by 27
Mechanobiology of Colorectal Cancer
Brás, M. M., Sousa, S. R., Carneiro, F., Radmacher, M., & Granja, P. L. (2022) · Cancers · doi:10.3390/cancers14081945 · Cited by 28
Weakly supervised segmentation on neural compressed histopathology with self-equivariant regularization
Chikontwe, P., Sung, H. J., Jeong, J., Kim, M., Go, H., Nam, S. J., & Park, S. H. (2022) · Medical Image Analysis · doi:10.1016/j.media.2022.102482 · Cited by 28
Chromosomal instability in adult-type diffuse gliomas
Richardson, T. E., Walker, J. M., Abdullah, K. G., McBrayer, S. K., Viapiano, M. S., Mussa, Z. M., Tsankova, N. M., Snuderl, M., & Hatanpaa, K. J. (2022) · Acta Neuropathologica Communications · doi:10.1186/s40478-022-01420-w · Cited by 27
Low-Level Microsatellite Instability as a Potential Prognostic Factor in Sporadic Colorectal Cancer
Lee, D., Kim, D., Lee, H. S., Ihn, M. H., Oh, H., Min, B. S., Kim, W. R., Huh, J. W., Yun, J.-A., Lee, K. Y., et al. (2015) · Medicine · doi:10.1097/md.0000000000002260 · Cited by 27
Hypermutated Tumors and Immune Checkpoint Inhibition
Ciombor, K. K., & Goldberg, R. M. (2018) · Drugs · doi:10.1007/s40265-018-0863-0 · Cited by 27
Silencing the GUCA2A-GUCY2C tumor suppressor axis in CIN, serrated, and MSI colorectal neoplasia
Bashir, B., Merlino, D. J., Rappaport, J. A., Gnass, E. D., Palazzo, J., Feng, Y., Fearon, E. R., Snook, A. E., & Waldman, S. A. (2019) · Human Pathology · doi:10.1016/j.humpath.2018.11.032 · Cited by 27
Urachal cancer—current concepts of a rare cancer
Reis, H., & Szarvas, T. (2019) · Der Pathologe · doi:10.1007/s00292-018-0516-9 · Cited by 27
Association of genetic variants for colorectal cancer differs by subtypes of polyps in the colorectum
Zhang, B., Shrubsole, M. J., Li, G., Cai, Q., Edwards, T. L., Smalley, W. E., Ness, R. M., & Zheng, W. (2012) · Carcinogenesis · doi:10.1093/carcin/bgs308 · Cited by 26
A deep learning-based multiscale integration of spatial omics with tumor morphology
Schmauch, B., Herpin, L., Olivier, A., Duboudin, T., Dubois, R., Gillet, L., Filiot, A., Schiratti, J.-B., Proietto, V. D., Corre, D. L., et al. (2025) · Nature Communications · doi:10.1038/s41467-025-66691-y · Cited by 26
Inflammation-Associated Microsatellite Alterations Caused by MSH3 Dysfunction Are Prevalent in Ulcerative Colitis and Increase With Neoplastic Advancement
Munakata, K., Koi, M., Kitajima, T., Tseng-Rogenski, S. S., Uemura, M., Matsuno, H., Kawai, K., Sekido, Y., Mizushima, T., Toiyama, Y., et al. (2019) · Clinical and Translational Gastroenterology · doi:10.14309/ctg.0000000000000105 · Cited by 26
The Human DNA Mismatch Repair Protein MSH3 Contains Nuclear Localization and Export Signals That Enable Nuclear-Cytosolic Shuttling in Response to Inflammation
Tseng-Rogenski, S. S., Munakata, K., Choi, D. H., Martin, P. K., Mehta, S. J., Koi, M., Zheng, W. H., Zhang, Y., & Carethers, J. M. (2020) · Molecular and Cellular Biology · doi:10.1128/mcb.00029-20 · Cited by 28
Adjuvant Chemotherapy in Microsatellite Instability-High Gastric Cancer
Kim, J. W., Cho, S., Chae, J., Kim, J., Kim, T., Lee, K., Oh, D., Bang, Y., & Im, S. (2020) · Cancer Research and Treatment · doi:10.4143/crt.2020.313 · Cited by 26
Pembrolizumab in unresectable or metastatic MSI-high colorectal cancer: safety and efficacy
Roth, M., & Das, S. (2020) · Expert Review of Anticancer Therapy · doi:10.1080/14737140.2021.1851201 · Cited by 28
Mismatch repair deficiency and clinicopathological characteristics in endometrial carcinoma: a systematic review and meta-analysis
Jumaah, A. S., Al‐Haddad, H. S., Salem, M. M., McAllister, K. A., & Yasseen, A. A. (2021) · Journal of Pathology and Translational Medicine · doi:10.4132/jptm.2021.02.19 · Cited by 27
Validation of Long Mononucleotide Repeat Markers for Detection of Microsatellite Instability
Lin, J. H., Chen, S., Pallavajjala, A., Guedes, L. B., Lotan, T. L., Bacher, J. W., & Eshleman, J. R. (2021) · Journal of Molecular Diagnostics · doi:10.1016/j.jmoldx.2021.10.011 · Cited by 27
Colorectal Neoplasia Pathways
IJspeert, J. E. G., Medema, J. P., & Dekker, E. (2015) · Gastrointestinal Endoscopy Clinics of North America · doi:10.1016/j.giec.2014.11.004 · Cited by 27
Histopathologic and Molecular Biomarkers of PD-1/PD-L1 Inhibitor Treatment Response among Patients with Microsatellite Instability‒High Colon Cancer
Hyung, J., Cho, E. J., Kim, J., Kim, J. H., Kim, J. E., Hong, Y. S., Kim, T. W., Sung, C. O., & Kim, S. Y. (2022) · Cancer Research and Treatment · doi:10.4143/crt.2021.1133 · Cited by 26
FBXW7 and Its Downstream NOTCH Pathway Could be Potential Indicators of Organ-Free Metastasis in Colorectal Cancer
Li, D., Jiang, S., Xin Min, Z. H. O. U., Si, C., Shao, P., Jiang, Q., Zhu, L., Shen, L., Meng, Q., Yin, J. C., et al. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2021.783564 · Cited by 26
Platform combining statistical modeling and patient-derived organoids to facilitate personalized treatment of colorectal carcinoma
Ramzy, G. M., Norkin, M., Koessler, T., Voirol, L., Tihy, M., Hany, D., McKee, T., Ris, F., Buchs, N. C., Docquier, M., et al. (2023) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-023-02650-z · Cited by 26
The pathological role of C-X-C chemokine receptor type 4 (CXCR4) in colorectal cancer (CRC) progression; special focus on molecular mechanisms and possible therapeutics
Hjazi, A. M., Nasir, F., Noor, R., Alsalamy, A., Zabibah, R. S., Romero‐Parra, R. M., Ullah, M. I., Mustafa, Y. F., Qasim, M. T., & Akram, S. V. (2023) · Pathology - Research and Practice · doi:10.1016/j.prp.2023.154616 · Cited by 32
Pan-cancer analysis of the prognostic and immunological role of GJB2: a potential target for survival and immunotherapy
Jia, Y., Guo, B., Zhang, W., Wang, F., Zhang, Y., Zhang, Q., & Li, E. (2023) · Frontiers in Oncology · doi:10.3389/fonc.2023.1110207 · Cited by 26
Unveiling the genetic and epigenetic landscape of colorectal cancer: new insights into pathogenic pathways
Postwala, H., Shah, Y., Parekh, P. S., & Chorawala, M. R. (2023) · Medical Oncology · doi:10.1007/s12032-023-02201-8 · Cited by 26
Hypothesis: Obesity Is Associated with a Lower Mutation Threshold in Colon Cancer
Bordonaro, M., & Lazarova, D. L. (2015) · Journal of Cancer · doi:10.7150/jca.12352 · Cited by 26
Annexin A10 expression correlates with serrated pathway features in colorectal carcinoma with microsatellite instability
Kim, J. H., Rhee, Y.-Y., Kim, K.-J., Cho, N., Lee, H. S., & Kang, G. H. (2014) · Apmis · doi:10.1111/apm.12284 · Cited by 26
Body Size, Physical Activity, Early-Life Energy Restriction, and Associations with Methylated Insulin-like Growth Factor–Binding Protein Genes in Colorectal Cancer
Simons, C. C. J. M., van den Brandt, P. A., Stehouwer, C. D. A., van Engeland, M., & Weijenberg, M. P. (2014) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-13-1285 · Cited by 26
Mismatch Repair Proteins and Microsatellite Instability in Colorectal Carcinoma (MLH1, MSH2, MSH6 and PMS2): Histopathological and Immunohistochemical Study
Ismael, N. E. H. S., Sheikh, S. A. E., Talaat, S. M., & Salem, E. M. (2017) · Open Access Macedonian Journal of Medical Sciences · doi:10.3889/oamjms.2017.003 · Cited by 28
Expending Role of Microsatellite Instability in Diagnosis and Treatment of Colorectal Cancers
Chang, L., Chang, M., Chang, H. M., & Chang, F. (2017) · Journal of Gastrointestinal Cancer · doi:10.1007/s12029-017-9991-0 · Cited by 30
Chang Wei Qing Decoction enhances the anti-tumor effect of PD-1 inhibitor therapy by regulating the immune microenvironment and gut microbiota in colorectal cancer
Wang, T., Wu, L., Wang, S., Shi, X., Liu, H., & Deng, W. (2023) · Chinese Journal of Natural Medicines · doi:10.1016/s1875-5364(23)60451-0 · Cited by 25
Chinese yam polysaccharide enhances anti-PD-1 immunotherapy in colorectal cancer through alterations in the gut microbiota and metabolites
Zhang, G., Pan, J., Xu, X., Nie, S., Lu, L., Jing, Y., Yang, F., Ji, G., & Xu, H. (2025) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2025.143323 · Cited by 29
Simplified MSI marker panel for diagnosis of colorectal cancer.
Shemirani, A. I., Haghighi, M. M., Zadeh, S. M., Fatemi, S. R., Taleghani, M. Y., Zali, N., Akbari, Z., Kashfi, S. M. H., & Zali, M. R. (2011) · PubMed · Cited by 25
Mitochondrial DNA Polymerase γ Mutations and Their Implications in mtDNA Alterations in Colorectal Cancer
Linkowska, K., Jawień, A., Marszałek, A., Malyarchuk, B. А., Tońska, K., Bartnik, E., Skonieczna, K., & Grzybowski, T. (2015) · Annals of Human Genetics · doi:10.1111/ahg.12111 · Cited by 25
Proximal Shift of Colorectal Cancer Along With Aging
Iida, Y., Kawai, K., Tsuno, N. H., Ishihara, S., Yamaguchi, H., Sunami, E., Kitayama, J., & Watanabe, T. (2014) · Clinical Colorectal Cancer · doi:10.1016/j.clcc.2014.06.005 · Cited by 25
Genomic and Epigenetic Instability in Colorectal Cancer
Safaei, A., Sobhi, S., Rezaei–Tavirani, M., & Zali, M. R. (2013) · Iranian Journal of Cancer Prevention · Cited by 26
Annexin A10 expression in colorectal cancers with emphasis on the serrated neoplasia pathway
Bae, J. M. (2015) · World Journal of Gastroenterology · doi:10.3748/wjg.v21.i33.9749 · Cited by 25
Molecular approach to genetic and epigenetic pathogenesis of early-onset colorectal cancer
Tezcan, G. (2016) · World Journal of Gastrointestinal Oncology · doi:10.4251/wjgo.v8.i1.83 · Cited by 25
Chromosomal instability analysis and regional tumor heterogeneity in colon cancer
Barresi, V., Castorina, S., Musso, N., Capizzi, C., Luca, T., Privitera, G., & Condorelli, D. F. (2016) · Cancer Genetics · doi:10.1016/j.cancergen.2016.11.001 · Cited by 25
Overexpression of MutL homolog 1 and MutS homolog 2 proteins have reversed prognostic implications for stage I–II colon cancer patients
Huang, S., Huang, S., Chen, Y., Chang, Y., Chiu, Y.-T., Chang, I., Wu, H. I., & Chen, J. (2017) · Biomedical Journal · doi:10.1016/j.bj.2017.01.004 · Cited by 25
SILAC-Based Quantification of TGFBR2-Regulated Protein Expression in Extracellular Vesicles of Microsatellite Unstable Colorectal Cancers
Fricke, F., Michalak, M., Warnken, U. H., Haußer, I., Schnölzer, M., Kopitz, J., & Gebert, J. F. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20174162 · Cited by 25
Immuno-Interface Score to Predict Outcome in Colorectal Cancer Independent of Microsatellite Instability Status
Nestarenkaitė, A., Fadhil, W., Rasmusson, A., Susanti, S., Hadjimichael, E., Laurinavičienė, A., Ilyas, M., & Laurinavičius, A. (2020) · Cancers · doi:10.3390/cancers12102902 · Cited by 27
Mismatch repair proteins play a role in ATR activation upon temozolomide treatment in MGMT-methylated glioblastoma
Ganesa, S., Sule, A. D., Sundaram, R. K., & Bindra, R. S. (2022) · Scientific Reports · doi:10.1038/s41598-022-09614-x · Cited by 25
Current Prognostic and Predictive Biomarkers for Endometrial Cancer in Clinical Practice: Recommendations/Proposal from the Italian Study Group
Zannoni, G. F., Bragantini, E., Castiglione, F., Fassan, M., Troncone, G., Inzani, F. S., Pesci, A., Santoro, A., & Fraggetta, F. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.805613 · Cited by 25
The Utility of Repetitive Cell-Free DNA in Cancer Liquid Biopsies
Deligezer, U., Bronkhorst, A. J., & Holdenrieder, S. (2022) · Diagnostics · doi:10.3390/diagnostics12061363 · Cited by 26
Neoadjuvant immunotherapy for dMMR/MSI-H locally advanced rectal cancer: The future new standard approach?
Cabezón‐Gutiérrez, L., Custodio‐Cabello, S., Palka-Kotlowska, M., Díaz-Pérez, D., Mateos-Domínguez, M., & Jara, P. G. (2022) · European Journal of Surgical Oncology · doi:10.1016/j.ejso.2022.10.018 · Cited by 26
Association between adenoma location and risk of recurrence
Pohl, H., Robertson, D. J., Mott, L. A., Ahnen, D. J., Burke, C. A., Barry, E. L., Bresalier, R. S., Figueiredo, J. C., Shaukat, A., Sandler, R. S., et al. (2016) · Gastrointestinal Endoscopy · doi:10.1016/j.gie.2016.02.048 · Cited by 25
Somatic mutations of the coding microsatellites within the beta-2-microglobulin gene in mismatch repair-deficient colorectal cancers and adenomas
On behalf of investigators from the Melbourne Collaborative Cohort Study and the Australasian Colorectal Cancer Family Registry Cohort, Clendenning, M., Huang, A., Jayasekara, H., Lorans, M., Preston, S., O’Callaghan, N., Pope, B. J., Macrae, F., Winship, I., et al. (2017) · Familial Cancer · doi:10.1007/s10689-017-0013-y · Cited by 25
Cimp-Positive Status is More Representative in Multiple Colorectal Cancers than in Unique Primary Colorectal Cancers
Tapial, S., López, S. O., Rueda, D., Arriba, M., Garcı́a, J. L., López, A. V., Pérez, J., Pena-Couso, L., Olivera-Salazar, R., Rodríguez, Y., et al. (2019) · Scientific Reports · doi:10.1038/s41598-019-47014-w · Cited by 25
Self-citation
New selective thiolate gold( i ) complexes inhibit the proliferation of different human cancer cells and induce apoptosis in primary cultures of mouse colon tumors
Abás, E., Pena-Martinez, R., Aguirre‐Ramírez, D., Rodríguez‐Diéguez, A., Laguna, M., & Grasa, L. (2020) · Dalton Transactions · doi:10.1039/c9dt04423j · Cited by 25
Analysis of Spatial Organization of Suppressive Myeloid Cells and Effector T Cells in Colorectal Cancer—A Potential Tool for Discovering Prognostic Biomarkers in Clinical Research
Zwing, N., Failmezger, H., Ooi, C.-H., Hibar, D. P., Cañamero, M., Gomes, B., Gaire, F., & Korski, K. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.550250 · Cited by 29
Clinical application of cytokine-induced killer (CIK) cell therapy in colorectal cancer: Current strategies and future challenges
Li, C. M. Y., Li, R., Drew, P. A., Price, T. J., Smith, E., Maddern, G. J., Tomita, Y., & Fenix, K. A. (2023) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2023.102665 · Cited by 25
Non-metastatic colon cancer: French Intergroup Clinical Practice Guidelines for diagnosis, treatments, and follow-up (TNCD, SNFGE, FFCD, GERCOR, UNICANCER, SFCD, SFED, SFRO, ACHBT, SFP, AFEF, and SFR)
Lecomte, T., Tougeron, D., Chautard, R., Bressand, D., Bibeau, F., Blanc, B., Cohen, R., Jacques, J., Lagasse, J.-P., Laurent‐Puig, P., et al. (2024) · Digestive and Liver Disease · doi:10.1016/j.dld.2024.01.208 · Cited by 25
Multi-parametric MRI Habitat Radiomics Based on Interpretable Machine Learning for Preoperative Assessment of Microsatellite Instability in Rectal Cancer
Wang, Y., Xie, B., Wang, K., Zou, W., Liu, A., Xue, Z., Liu, M., & Ma, Y. (2025) · Academic Radiology · doi:10.1016/j.acra.2025.02.009 · Cited by 24
Genetic heterogeneity in synchronous colorectal cancers impacts genotyping approaches and therapeutic strategies
Jesinghaus, M., Pfarr, N., Kloor, M., Endris, V., Tavernar, L., Muckenhuber, A., Doeberitz, M. V. K., Penzel, R., Weichert, W., & Stenzinger, A. (2015) · Genes Chromosomes and Cancer · doi:10.1002/gcc.22330 · Cited by 25
Novel candidates in early-onset familial colorectal cancer
Jansen, A. M. L., Ghosh, P., Dakal, T. C., Slavin, T. P., Boland, C. R., & Goel, A. (2019) · Familial Cancer · doi:10.1007/s10689-019-00145-5 · Cited by 24
Self-citation
MSH6 immunohistochemical heterogeneity in colorectal cancer: comparative sequencing from different tumor areas
Chen, W., Pearlman, R., Hampel, H., Pritchard, C. C., Markow, M., Arnold, C. A., Knight, D. A., & Frankel, W. L. (2019) · Human Pathology · doi:10.1016/j.humpath.2019.11.003 · Cited by 24
WRN-Mutated Colorectal Cancer Is Characterized by a Distinct Genetic Phenotype
Zimmer, K., Puccini, A., Xiu, J., Baca, Y., Spizzo, G., Lenz, H., Battaglin, F., Goldberg, R. M., Grothey, A. F., Shields, A. F., et al. (2020) · Cancers · doi:10.3390/cancers12051319 · Cited by 24
Colorectal Cancer in Octogenarian and Nonagenarian Patients: Clinicopathological Features and Survivals
Lee, S. M., & Shin, J. S. (2020) · Annals of Coloproctology · doi:10.3393/ac.2020.01.19.2 · Cited by 23
Pan-Cancer Analysis of PIMREG as a Biomarker for the Prognostic and Immunological Role
Zhu, H., Hu, X., Ye, Y., Jian, Z., Zhong, Y., Gu, L., & Xiong, X. (2021) · Frontiers in Genetics · doi:10.3389/fgene.2021.687778 · Cited by 24
Deciphering the etiology and role in oncogenic transformation of the CpG island methylator phenotype: a pan-cancer analysis
Yates, J., & Boeva, V. (2022) · Briefings in Bioinformatics · doi:10.1093/bib/bbab610 · Cited by 24
Innovative methods for biomarker discovery in the evaluation and development of cancer precision therapies
Umelo, I. A., Costanza, B., & Castronovo, V. (2018) · Cancer and Metastasis Reviews · doi:10.1007/s10555-017-9710-0 · Cited by 23
Signs of carcinogenicity induced by parathion, malathion, and estrogen in human breast epithelial cells (Review)
Calaf, G. M., Bleak, T. C., & Roy, D. (2021) · Oncology Reports · doi:10.3892/or.2021.7975 · Cited by 27
Analysis of Concordance Between Next-Generation Sequencing Assessment of Microsatellite Instability and Immunohistochemistry-Mismatch Repair From Solid Tumors
Fehmi, R.-A., Krause, H. B., Morris, R. T., Wallbillich, J. J., Corey, L., Bandyopadhyay, S., Kheil, M. H., Elbashir, L. M., Zaiem, F., Quddus, M. R., et al. (2024) · JCO Precision Oncology · doi:10.1200/po.23.00648 · Cited by 23
Developing proteomics‐based biomarkers for colorectal neoplasms for clinical practice: Opportunities and challenges
Luo, Y., Wang, L., & Wang, J. (2012) · PROTEOMICS - CLINICAL APPLICATIONS · doi:10.1002/prca.201200071 · Cited by 23
Comprehensive Evaluation of Protein Coding Mononucleotide Microsatellites in Microsatellite-Unstable Colorectal Cancer
Kondelin, J., Gylfe, A. E., Lundgren, S., Tanskanen, T. J., Hamberg, J., Aavikko, M., Palin, K., Ristolainen, H., Katainen, R., Kaasinen, E., et al. (2017) · Cancer Research · doi:10.1158/0008-5472.can-17-0682 · Cited by 26
Clinical and prognostic differences between surgically resected right-sided and left-sided colorectal cancer
Fukata, K., Yuasa, N., Takeuchi, E., Miyake, H., Nagai, H., Yoshioka, Y., & Miyata, K. (2019) · Surgery Today · doi:10.1007/s00595-019-01889-4 · Cited by 23
Microsatellite Instability assessment in Black South African Colorectal Cancer patients reveal an increased incidence of suspected Lynch syndrome
McCabe, M., Perner, Y., Magobo, R. E., Magangane, P. S., Mirza, S., & Penny, C. B. (2019) · Scientific Reports · doi:10.1038/s41598-019-51316-4 · Cited by 23
Unveiling the immune infiltrate modulation in cancer and response to immunotherapy by MIXTURE—an enhanced deconvolution method
Fernández, E. A., Mahmoud, Y. D., Veigas, F., Rocha, D., Miranda, M., Merlo, J. P., Balzarini, M., Luján, H. D., Rabinovich, G. A., & Girotti, M. R. (2020) · Briefings in Bioinformatics · doi:10.1093/bib/bbaa317 · Cited by 23
Heterogeneity of Colorectal Cancer Progression: Molecular Gas and Brakes
Gaiani, F., Marchesi, F., Negri, F., Greco, L., Malesci, A., de’Angelis, G. L., & Laghi, L. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22105246 · Cited by 24
Genetic predisposition to lymphomas: Overview of rare syndromes and inherited familial variants
Szmyd, B. M., Mlynarski, W. M., & Pastorczak, A. K. (2021) · Mutation Research/Reviews in Mutation Research · doi:10.1016/j.mrrev.2021.108386 · Cited by 23
Examination of Gene Loss in the DNA Mismatch Repair Pathway and Its Mutational Consequences in a Fungal Phylum
Phillips, M. A., Steenwyk, J. L., Shen, X., & Rokas, A. (2021) · Genome Biology and Evolution · doi:10.1093/gbe/evab219 · Cited by 21
Single-Agent Neoadjuvant Immunotherapy With a PD-1 Antibody in Locally Advanced Mismatch Repair-Deficient or Microsatellite Instability-High Colorectal Cancer
Pei, F., Wu, J., Zhao, Y., He, W., Yao, Q., Huang, M., & Huang, J. C. (2022) · Clinical Colorectal Cancer · doi:10.1016/j.clcc.2022.11.004 · Cited by 22
Overexpression and Role of HHLA2, a Novel Immune Checkpoint, in Colorectal Cancer
Kula, A., Dawidowicz, M., Mielcarska, S., Kiczmer, P., Skiba, H., Krygier, M., Chrabańska, M., Piecuch, J., Szrot, M., Robotycka, J., et al. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24065876 · Cited by 23
The Gut Microbiome, Microsatellite Status and the Response to Immunotherapy in Colorectal Cancer
Sillo, T. O., Beggs, A. D., Middleton, G., & Akingboye, A. A. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24065767 · Cited by 25
Prediction of Microsatellite Instability in Colorectal Cancer Using a Machine Learning Model Based on PET/CT Radiomics
Kim, S., Lee, J., Park, E. J., Lee, H. S., Baik, S. H., Jeon, T. J., Lee, K. Y., Ryu, Y. H., & Kang, J. (2023) · Yonsei Medical Journal · doi:10.3349/ymj.2022.0548 · Cited by 23
Efficacy of PD-1 inhibitors for colorectal cancer and polyps in Lynch syndrome patients
Yu, J., Xiao, B., Tang, J., Li, D., Wang, F., Ding, Y., Han, K., Kong, L.-H., Ling, Y., Mei, W.-J., et al. (2023) · European Journal of Cancer · doi:10.1016/j.ejca.2023.113253 · Cited by 23
Functional polymorphism in the MicroRNA-367 binding site as a prognostic factor for colonic cancer.
Chae, Y. S., Kim, J. G., Kang, B. W., Lee, S. J., Lee, Y. J., Park, J. S., Choi, G., Lee, W. K., & Jeon, H. S. (2013) · PubMed · Cited by 23
Overexpressed transcription factor FOXM1 contributes to the progression of colorectal cancer
Zhang, H., Zhong, H., Li, L., Ji, W., & Zhang, X. (2016) · Molecular Medicine Reports · doi:10.3892/mmr.2016.4875 · Cited by 25
Stratified analysis reveals chemokine-like factor (CKLF) as a potential prognostic marker in the MSI-immune consensus molecular subtype CMS1 of colorectal cancer
Dunne, P. D., O’Reilly, P. G., Coleman, H. G., Gray, R. T., Longley, D. B., Johnston, P. G., Salto‐Tellez, M., Lawler, M., & McArt, D. G. (2016) · Oncotarget · doi:10.18632/oncotarget.9126 · Cited by 23
The differential expression of omega-3 and omega-6 fatty acid metabolising enzymes in colorectal cancer and its prognostic significance
Alnabulsi, A., Swan, R., Cash, B., Alnabulsi, A., & Murray, G. (2017) · British Journal of Cancer · doi:10.1038/bjc.2017.135 · Cited by 23
En bloc endoscopic mucosal resection is equally effective for sessile serrated polyps and conventional adenomas
Agarwal, A., Garimall, S., Scott, F. I., Ahmad, N. A., Kochman, M. L., Ginsberg, G. G., & Chandrasekhara, V. (2017) · Surgical Endoscopy · doi:10.1007/s00464-017-5876-3 · Cited by 23
Mlh1 deficiency in normal mouse colon mucosa associates with chromosomally unstable colon cancer
Pussila, M., Törönen, P., Einarsdóttir, E., Katayama, S., Krjutškov, K., Holm, L., Kere, J., Peltomäki, P., Mäkinen, M. J., Lindén, J., et al. (2018) · Carcinogenesis · doi:10.1093/carcin/bgy056 · Cited by 22
Additional loss of MSH2 and MSH6 expression in sporadic deficient mismatch repair colorectal cancer due to MLH1 promoter hypermethylation
Westwood, A. C., Glover, A. C., Hutchins, G. G. A., Young, C., Brockmoeller, S. F., Robinson, R., Worrilow, L., Wallace, D., Rankeillor, K., Adlard, J., et al. (2019) · Journal of Clinical Pathology · doi:10.1136/jclinpath-2018-205687 · Cited by 23
Immunotherapy in Solid Tumors and Gut Microbiota: The Correlation—A Special Reference to Colorectal Cancer
Koulouridi, A., Messaritakis, I., Gouvas, N., Tsiaoussis, J., & Souglakos, J. (2020) · Cancers · doi:10.3390/cancers13010043 · Cited by 26
Predictive and prognostic biomarkers with therapeutic targets in colorectal cancer: A 2021 update on current development, evidence, and recommendation
Chung, C. (2021) · Journal of Oncology Pharmacy Practice · doi:10.1177/10781552211005525 · Cited by 24
Recognizing Paradigm Instability in Theories of Carcinogenesis
Baker, S. G. (2014) · Journal of Advances in Medicine and Medical Research · doi:10.9734/bjmmr/2014/6855 · Cited by 26
Chronic Inflammation, Colorectal Cancer and Gene Polymorphisms
Boland, C. R. (2010) · Digestive Diseases · doi:10.1159/000320053 · Cited by 24
Self-citation
Prognostic implications of EGFR protein expression in sporadic colorectal tumors: Correlation with copy number status, mRNA levels and miRNA regulation
del Carmen, S., Corchete, L. A., Gervas, R., Rodriguez, A., Garcia, M., Álcazar, J. A., García, J., Bengoechea, O., Muñoz-Bellvis, L., Sayagués, J. M., et al. (2020) · Scientific Reports · doi:10.1038/s41598-020-61688-7 · Cited by 18

Authors: Boland, C. R., & Goel, A.
Affiliations: Baylor University Medical Center (US)
Corresponding author: Boland, C. Richard
ORCID: Boland, C. Richard
Goel, Ajay
Venue: Gastroenterology
Publisher: Elsevier BV
Published: 2010-05
Volume: 138
Issue: 6
Pages: 2073-2087.e3
ISSN: 0016-5085 (ISSN-L)
DOI: 10.1053/j.gastro.2009.12.064
PMC: PMC3037515
OpenAlex: W2094390470
Cited by: 2,456
References: 228
Citations by year: 2026: 140 · 2025: 201 · 2024: 202 · 2023: 191 · 2022: 257 · 2021: 211 · 2020: 194 · 2019: 160 · 2018: 140 · 2017: 115 · 2016: 112 · 2015: 117 · 2014: 111 · 2013: 100 · 2012: 94
FWCI: 11.76
Type: journal article
Language: en
Open access: green
www.ncbi.nlm.nih.gov
Licence: www.elsevier.com/tdm/userlicense/1.0/ (tdm)
www.elsevier.com/legal/tdmrep-license (tdm)
Locations: Gastroenterology (publishedVersion)
PubMed (publishedVersion)
PubMed Central (acceptedVersion)
Funders: National Institutes of Health (R01 CA129286, R01 CA72851)
National Cancer Institute
Topics: Health Sciences › Medicine › Pathology and Forensic Medicine › Genetic factors in colorectal cancer
Health Sciences › Medicine › Oncology › Colorectal Cancer Treatments and Studies
Health Sciences › Medicine › Oncology › Colorectal Cancer Surgical Treatments
Keywords: microsatellite instability, colorectal cancer, DNA mismatch repair, Lynch syndrome, MLH1 promoter methylation, CpG island methylator phenotype, proximal colon tumors, lymphocyte infiltration, mucinous tumors, signet ring cell carcinoma, prognosis, chemotherapy response
MeSH terms: Animals, Cell Transformation, Neoplastic, Colorectal Neoplasms, Hereditary Nonpolyposis, Humans, Mutation, Phenotype, Risk Factors, Colorectal Neoplasms, Gene Expression Regulation, Neoplastic, Treatment Outcome, Genetic Predisposition to Disease, Microsatellite Instability, DNA Mismatch Repair

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Microsatellite Instability in Colorectal Cancer

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks